Boyer & Corporon Wealth Management, LLC Novartis Ag Transaction History

Boyer & Corporon Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$85.54 - $94.26 $3.23 Million - $3.56 Million	-37,744 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$75.4 - $92.8 $41,545 - $51,132	551 Added 1.48%	37,744 $3.45 Million
Q1 2019 May 08, 2019	BUY	$75.32 - $86.15 $16,043 - $18,349	213 Added 0.58%	37,193 $3.58 Million
Q4 2018 Feb 14, 2019	SELL	$73.66 - $82.02 $74,764 - $83,250	-1,015 Reduced 2.67%	36,980 $31.7 Million
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $14,191 - $16,415	212 Added 0.56%	37,995 $3.22 Million
Q2 2018 Aug 08, 2018	BUY	$64.91 - $73.36 $99,507 - $112,460	1,533 Added 4.23%	37,783 $2.85 Million
Q1 2018 May 14, 2018	BUY	$70.39 - $84.15 $42,656 - $50,994	606 Added 1.7%	36,250 $2.93 Million
Q4 2017 Feb 13, 2018	BUY	$72.33 - $77.64 $39,130 - $42,003	541 Added 1.54%	35,644 $2.99 Million
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $2.6 Million - $2.71 Million	35,103	35,103 $3.01 Million

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Boyer & Corporon Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boyer & Corporon Wealth Management, LLC with notifications on news.